- Orforglipron is a new medication for overweight and obesity
- The medication is not yet approved or available
- Medication in tablet form
- Clinical studies to date show a potential weight loss of up to 12%
- Current side effects appear similar to those of other GLP-1 medications

About Orforglipron
What is orforglipron?
Orforglipron is a new, oral treatment being studied for people who are overweight or have obesity. The drug belongs to the group of medicines known as GLP-1 receptor agonists. This medicine works in a similar way to some existing injectable treatments for weight loss, but comes in a tablet form. It is also being studied as a treatment for type 2 diabetes. The medicine is still undergoing clinical trials and is therefore not yet available or approved for use in the European Union. As soon as this changes, we will keep you up to date.



